Fate therapeutics announces participation in upcoming investor conferences

San diego, nov. 12, 2020 (globe newswire) -- fate therapeutics, inc. (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced its participation in the following upcoming investor conferences:

FATE Ratings Summary

FATE Quant Ranking